These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3735317)

  • 1. 2-Alkyl-substituted 1,1-bis(4-acetoxyphenyl)-2-phenylethenes. Estrogen receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activity.
    Schneider MR
    J Med Chem; 1986 Aug; 29(8):1494-8. PubMed ID: 3735317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol estrogens of the 1,1,2-triphenylbut-1-ene type: relationship between structure, estradiol receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activities.
    Schneider MR; Ball H; Schiller CD
    J Med Chem; 1986 Aug; 29(8):1355-62. PubMed ID: 3016262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanes.
    Hartmann RW; Schwarz W; Heindl A; Schönenberger H
    J Med Chem; 1985 Sep; 28(9):1295-301. PubMed ID: 2993619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting properties.
    Schneider MR; Ball H; Schönenberger H
    J Med Chem; 1985 Dec; 28(12):1880-5. PubMed ID: 4068009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrols.
    Hartmann RW; Heindl A; Schwarz W; Schönenberger H
    J Med Chem; 1984 Jul; 27(7):819-24. PubMed ID: 6330356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Alkyl-2-phenylbenzo[b]thiophenes: nonsteroidal estrogen antagonists with mammary tumor inhibiting activity.
    von Angerer E; Erber S
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):557-62. PubMed ID: 1562527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of alkyl chain ramification on estradiol receptor binding affinity and intrinsic activity of 1,2-dialkylated 1,2-bis(4- or 3-hydroxyphenyl)ethane estrogens and antiestrogens.
    Hartmann RW
    J Med Chem; 1986 Sep; 29(9):1668-74. PubMed ID: 3018243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetoxy substituted 1,1,2-triphenylbut-1-enes: estrogenic, antiestrogenic and mammary tumor inhibiting activity.
    Schneider MR
    J Cancer Res Clin Oncol; 1986; 112(2):119-24. PubMed ID: 3771620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Alkyl-12-formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity.
    Polossek T; Ambros R; von Angerer S; Brandl G; Mannschreck A; von Angerer E
    J Med Chem; 1992 Sep; 35(19):3537-47. PubMed ID: 1404234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations on estrogen receptor binding. The estrogenic, antiestrogenic, and cytotoxic properties of C2-alkyl-substituted 1,1-bis(4-hydroxyphenyl)-2-phenylethenes.
    Lubczyk V; Bachmann H; Gust R
    J Med Chem; 2002 Nov; 45(24):5358-64. PubMed ID: 12431063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,2-dialkyl-1,2-bis(3'-hydroxyphenyl)ethanes.
    Hartmann RW; Buchborn H; Kranzfelder G; Schönenberger H; Bogden A
    J Med Chem; 1981 Oct; 24(10):1192-7. PubMed ID: 6276542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.
    Schertl S; Hartmann RW; Batzl-Hartmann C; Schlemmer R; Spruss T; Bernhardt G; Gust R; Schönenberger H
    Arch Pharm (Weinheim); 2001 Apr; 334(4):125-37. PubMed ID: 11382148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of alkyl-chain fluorination on the action of mammary tumor inhibiting 2,3-bis(hydroxyphenyl)butanes and 2,3-bis(hydroxyphenyl)but-2-enes.
    Hartmann RW; Heindl A; Schneider MR; Schönenberger H
    J Med Chem; 1986 Mar; 29(3):322-8. PubMed ID: 3005573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity.
    von Angerer E; Strohmeier J
    J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dibenzo[a,f]quinolizines: syntheses and cytostatic activity in estrogen-sensitive tumor cells.
    von Angerer S; Seidl E; Mannschreck A; von Angerer E; Wiegrebe W
    Anticancer Drug Des; 1994 Feb; 9(1):25-40. PubMed ID: 8141964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Phenylindenes: development of a new mammary tumor inhibiting antiestrogen by combination of estrogenic side effect lowering structural elements.
    Schneider MR; Ball H
    J Med Chem; 1986 Jan; 29(1):75-9. PubMed ID: 3941415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-(Hydroxyphenyl)indoles: a new class of mammary tumor inhibiting compounds.
    von Angerer E; Prekajac J
    J Med Chem; 1983 Jan; 26(1):113-6. PubMed ID: 6402593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Phenylindoles with sulfur containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activity.
    Biberger C; von Angerer E
    J Steroid Biochem Mol Biol; 1996 Apr; 58(1):31-43. PubMed ID: 8809184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1,2 -diphenylethanes.
    Hartmann RW; Kranzfelder G; von Angerer E; Schönenberger H
    J Med Chem; 1980 Aug; 23(8):841-8. PubMed ID: 7401112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.